Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Prescreening Study to Identify Potential Participants With ABCA4-related Retinopathy for ACDN-01 Clinical Trials

Authors not listed

Ascidian Therapeutics, Inc · 2024

Abstract

This is an observational prescreening study. Individuals who are eligible for prescreening will undergo testing procedures that may be used to determine eligibility in ACDN-01 clinical trials.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-12 MST

Cite this

APA
Anonymous. (2024). Prescreening Study to Identify Potential Participants With ABCA4-related Retinopathy for ACDN-01 Clinical Trials. <em>Ascidian Therapeutics, Inc</em>. https://clinicaltrials.gov/study/NCT06445322
Vancouver
Anonymous. Prescreening Study to Identify Potential Participants With ABCA4-related Retinopathy for ACDN-01 Clinical Trials. Ascidian Therapeutics, Inc. 2024.
BibTeX
@misc{anon2024Prescr, title = {Prescreening Study to Identify Potential Participants With ABCA4-related Retinopathy for ACDN-01 Clinical Trials}, author = {Anonymous}, journal = {Ascidian Therapeutics, Inc}, year = {2024}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings